New Pharmaceutical Companies in Holly Springs

Located near the southernmost section of Wake County, 30 minutes southwest of Raleigh, Holly Springs is in the midst of a transformation—from a quaint suburb into a burgeoning hub of innovation. Major players in the global pharmaceutical and biotechnologies segment have taken notice. Already home to a production and manufacturing plant for the Australia-based bioscience firm CSL Seqirus, the town's profile is set to further expand with the addition of two strategic and highly lucrative economic developments.

FUJIFILM Diosynth Biotechnologies, a leading contract development and manufacturing organization (CDMO), recently selected Holly Springs as the site for its largest cell culture biopharmaceutical facility in North America. Scheduled to become operational in 2025, this state-of-the-art, 839,000-square-foot facility, spread across over 150 acres, will feature eight 20,000-liter bioreactors for large-scale drug substance production.

The company's decision to expand in Holly Springs, including significant transportation and infrastructure improvements, underscores the town's reputation as a global biomanufacturing hub. FUJIFILM's Holly Springs facility will bring cutting-edge technology to the region and foster a vibrant workplace culture of innovation, sustainability, and community engagement.

The company has already announced a $1.2 billion expansion plan for the facility and the creation of 680 jobs, highlighting its long-term commitment to the town and surrounding region. Ultimately, this project will boost the local economy with an overall investment of $3.2 billion, add more than 1,400 jobs, increase high-tech job opportunities, and solidify Holly Springs' status as a critical player in the global biopharmaceutical industry.

Similarly, biotech giant Amgen is rapidly progressing on its own large-scale development project, which further cements the town's reputation as a center for life sciences and advanced biopharmaceutical research, development, and manufacturing. The $550 million, 350,000-square-foot facility represents Amgen's commitment to advancing drug manufacturing through innovative processes and sustainable practices. Amgen's Holly Springs site will play a crucial role in the company's global manufacturing network, focusing on the production of medicines that address serious diseases.

The facility will become operational in 2025 and will prove vital to jump-starting the town's Camp Helix Life Science and Manufacturing campus. Sitting adjacent to the Amgen plant, Camp Helix is a 650-acre, 3.5 million square foot live-work-play mixed-used development designed especially for companies and residents supporting the cutting-edge manufacturing of biologics, pharmaceuticals, semiconductors, and other technologies.

Amgen's investment in Holly Springs is part of a broader trend of biopharmaceutical companies choosing North Carolina as their operational base. The state's robust infrastructure, skilled workforce, and supportive business environment make it an attractive destination for companies looking to expand their footprint in the U.S. Amgen's facility will enhance its manufacturing capabilities and contribute to the growth and development of the local economy.

FUJIFILM Diosynth Biotechnologies and Amgen's decisions to establish significant operations in Holly Springs reflect the town's growing appeal as a strategic business location. The city offers a unique combination of high-tech opportunities and a community-centric atmosphere, making it ideal for companies looking to innovate while providing their employees with an excellent quality of life.

With its advantageous location—20 minutes from Research Triangle Park in Durham and 30 minutes from the University of North Carolina at Chapel Hill and Duke University and the Duke Clinical Research Facility—Holly Springs offers the perfect blend of small-town charm and metropolitan convenience, making it ideal for both residents and businesses alike.

Boasting top-rated schools, abundant green spaces, and a strong sense of community, Holly Springs has become one of the most alluring places for families and professionals seeking a high quality of life.

For residents, the arrival of these global companies means more than just economic growth; it represents the town's evolution into a dynamic place where cutting-edge industries meet a welcoming and vibrant community.

As Holly Springs continues to attract leading companies like FUJIFILM Diosynth Biotechnologies and Amgen, the town is poised to become a significant player on the global stage. For anyone looking to be part of a community shaping the future, Holly Springs is the place to be.

If you're interested in learning more about Holly Springs' luxury real estate market, including the area's top neighborhoods and luxury home inventory, contact Crumpler Realty Group today to begin your Holly Springs real estate journey. Allow our years of extensive experience and expertise to help you navigate one of the Research Triangles' most dynamic and sought-after home markets.